https://www.indianpharmapost.com/merck-to-initiate-new-phase-3-clinical-program-for-treatment-of-hiv-1-infection-130372022-09-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/quinten-health-closes-its-financing-round-to-advance-disease-modeling-platforms-130452022-09-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/dolomite-bio-launches-an-affordable-microfluidic-system-for-custom-protocol-development-130442022-09-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/evusheld-long-acting-antibody-combination-approved-in-the-eu-for-the-treatment-of-covid-19-130432022-09-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/tezspire-approved-in-the-eu-for-the-treatment-of-severe-asthma-130422022-09-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/natco-gets-ctpr-launch-approval-from-delhi-high-court-130412022-09-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/daman-enters-ambitious-european-precision-medicine-healthcare-project-130402022-09-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/medical-devices-market-in-singapore-to-reach-35-billion-in-2022-forecasts-globaldata-130392022-09-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/azelis-expands-pharmaceutical-offerings-with-clariant-130382022-09-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/dme-market-across-7mm-set-to-reach-111-billion-in-2031-forecasts-globaldata-130462022-09-21T00:00:00+05:30always0.9